[{"id":"a814259a-a8c1-4ee2-ab56-308f9e50f558","acronym":"","url":"https://clinicaltrials.gov/study/NCT05978284","created_at":"2023-08-07T14:08:46.766Z","updated_at":"2024-07-02T16:35:30.517Z","phase":"Phase 1/2","brief_title":"Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma","source_id_and_acronym":"NCT05978284","lead_sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","biomarkers":" DLL3","pipe":"","alterations":" ","tags":["DLL3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e alveltamig (ZG006)"],"overall_status":"Recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 10/27/2023","start_date":" 10/27/2023","primary_txt":" Primary completion: 09/01/2025","primary_completion_date":" 09/01/2025","study_txt":" Completion: 10/01/2025","study_completion_date":" 10/01/2025","last_update_posted":"2023-11-03"}]